CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro

Published:2014-12-16 Issue:2 Volume:35 Page:340-348
ISSN:1107-3756
Container-title:International Journal of Molecular Medicine
language:en
Short-container-title:

Author:

ZHU ZHUANGYAN,MU YAQIN,QI CAIXIA,WANG JIAN,XI GUOPING,GUO JUNCHENG,MI RUORAN,ZHAO FUXI

Publisher

Spandidos Publications

Subject

Genetics,General Medicine

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long noncoding RNAs as potential targets for overcoming chemoresistance in upper gastrointestinal cancers;Biomedicine & Pharmacotherapy;2024-10

2. Long-term zinc treatment alters the mechanical properties and metabolism of prostate cancer cells;Cancer Cell International;2024-09-11

3. Prognostic Value of Fatty Acid Metabolism-related Genes in Patients with Bladder Cancer;Recent Patents on Anti-Cancer Drug Discovery;2024-08

4. Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization;European Urology;2024-08

5. Targeting estrogen metabolism in high-grade serous ovarian cancer shows promise to overcome platinum resistance;Biomedicine & Pharmacotherapy;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP